Novel Bispecific Aptamer Enhances Immune Cytotoxicity Against MUC1-Positive Tumor Cells by MUC1-CD16 Dual Targeting
Molecules - Switzerland
doi 10.3390/molecules24030478
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 29, 2019
Authors
Publisher
MDPI AG